Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional
Official Title: A Single Arm Phase II Study Of The Dual mTORC1/mTORC2 Inhibitor Vistusertib (AZD2014) Provided On An Intermittent Schedule For Sporadic Patients With Grade II-III Meningiomas
Brief Summary:
This research study is studying a chemotherapy as a possible treatment for Meningiomas (recurrent).
The study intervention involved in this study is:
--AZD2014 (vistusertib)